NVAX Bearish Positioning
Novavax Inc. (NVAX) continues to be a heavily shorted name in the biotech sector. Recent data confirms that 49,880,000 shares are currently sold short. With a days-to-cover ratio of 11.0, the stock exhibits a persistent bearish overhang. This level of short interest suggests that market participants remain skeptical of the company's near-term prospects. Traders should watch for any shifts in borrow availability or price action that could trigger a short squeeze, given the significant volume of shares currently committed to the short side.
Signal data sourced from ShortSqueeze. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.